Advertisement

Click here for more guidelines.
2012 ACCF/ AATS/ SCAI/ STS Expert Consensus Document on Transcatheter Aortic Valve Replacement
ACCF/ SCAI/ STS/ AATS/ AHA/ ASNC/ HFSA/ SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update
2012 ACCF/ AHA/ ACR/ SCAI/ SIR/ STS/ SVM/ SVN Key Data Elements and Definitions for Peripheral Atherosclerotic Vascular Disease

 
About JACC CME
Policy on Privacy and Confidentiality
Disclosures
Important Information
 

JACC Imaging Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?
Click here
to sign up now!

Submit Manuscripts
Author Information
Subscribe/Renew
Order Reprints
Email Alerts
Feedback
RSS Feed
CME
 
 

Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions
 
 

About the Journal
Editorial Board & Staff
 
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2005; 46:231-236, doi:10.1016/j.jacc.2005.01.062 (Published online 5 July 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2005.01.062v1
46/2/231    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Togni, M.
Right arrow Articles by Hess, O. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Togni, M.
Right arrow Articles by Hess, O. M.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY

Sirolimus-Eluting Stents Associated With Paradoxic Coronary Vasoconstriction

Mario Togni, MD, Stephan Windecker, MD, Rosangela Cocchia, MD, Peter Wenaweser, MD, Stephane Cook, MD, Michael Billinger, MD, Bernhard Meier, MD, FACC and Otto M. Hess, MD, FACC*

Swiss Cardiovascular Center Bern, Bern, Switzerland

Manuscript received October 11, 2004; revised manuscript received December 27, 2004, accepted January 11, 2005.

* Reprint requests and correspondence: Dr. Otto M. Hess, Professor of Cardiology, Swiss Cardiovascular Center, Inselspital, CH-3010 Bern, Switzerland (Email: otto.hess{at}insel.ch).

OBJECTIVES: The purpose of the present study was to assess coronary vasomotor response to exercise after sirolimus-eluting stent (SES) implantation.

BACKGROUND: Sirolimus-eluting stents have been shown to markedly reduce the incidence of angiographic and clinical restenosis. However, long-term effects of sirolimus on endothelial function are unknown.

METHODS: Coronary vasomotion was evaluated with biplane quantitative coronary angiography at rest and during supine bicycle exercise in 25 patients with coronary artery disease. Eleven patients were treated with a bare-metal stent (BMS) (control group) and 14 patients underwent SES implantation (sirolimus group) for de novo coronary artery lesions. Both groups were studied 6 ± 1 month after the intervention. Minimal luminal diameter; stent diameter; and proximal, distal, and reference vessel diameter were determined.

RESULTS: The reference vessel showed exercise-induced vasodilation (+13 ± 4%) in both groups. Vasomotion within the stented vessel segments was abolished. In controls, the adjacent segments proximal and distal to the stent showed exercise-induced vasodilation (+15 ± 3% and +17 ± 4%, respectively). In contrast, there was exercise-induced vasoconstriction of the proximal and distal vessel segments adjacent to SESs (–12 ± 4% and –15 ± 6%, respectively; p < 0.001 vs. corresponding segments of controls). Sublingual nitroglycerin was associated with maximal vasodilation of the proximal and distal vessel segments in both groups.

CONCLUSIONS: Implantation of a BMS does not affect physiologic response to exercise proximal and distal to the stent. However, SESs are associated with exercise-induced paradoxic coronary vasoconstriction of the adjacent vessel segments, although vasodilatory response to nitroglycerin is maintained. These observations suggest (drug-induced) endothelial dysfunction as the underlying mechanism.

Abbreviations and Acronyms
  BMS = bare-metal stent
  NO = nitric oxide
  NTG = nitroglycerin
  SES = sirolimus-eluting stent


Related Article

Endothelial Dysfunction After Sirolimus-Eluting Stent Placement
Rod Serry and William F. Penny
J. Am. Coll. Cardiol. 2005 46: 237-238. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 J Am Coll Cardiol IntvHome page
S. Brugaletta, J. Gomez-Lara, P. W. Serruys, V. Farooq, R. J. van Geuns, L. Thuesen, D. Dudek, J. Koolen, B. Chevalier, D. McClean, et al.
Serial In Vivo Intravascular Ultrasound-Based Echogenicity Changes of Everolimus-Eluting Bioresorbable Vascular Scaffold During the First 12 Months After Implantation: Insights From the ABSORB B Trial
J. Am. Coll. Cardiol. Intv., December 1, 2011; 4(12): 1281 - 1289.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
T. Inoue, K. Croce, T. Morooka, M. Sakuma, K. Node, and D. I. Simon
Vascular Inflammation and Repair: Implications for Re-Endothelialization, Restenosis, and Stent Thrombosis
J. Am. Coll. Cardiol. Intv., October 1, 2011; 4(10): 1057 - 1066.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol ImgHome page
M. J. Suter, S. K. Nadkarni, G. Weisz, A. Tanaka, F. A. Jaffer, B. E. Bouma, and G. J. Tearney
Intravascular Optical Imaging Technology for Investigating the Coronary Artery
J. Am. Coll. Cardiol. Img., September 1, 2011; 4(9): 1022 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
M. Klomp, M. A. Beijk, C. Varma, J. J. Koolen, E. Teiger, G. Richardt, F. Bea, N. van Geloven, N. J. Verouden, Y. K. Chan, et al.
1-Year Outcome of TRIAS HR (TRI-Stent Adjudication Study-High Risk of Restenosis): A Multicenter, Randomized Trial Comparing Genous Endothelial Progenitor Cell Capturing Stents With Drug-Eluting Stents
J. Am. Coll. Cardiol. Intv., August 1, 2011; 4(8): 896 - 904.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
R. Tsuburaya, S. Yasuda, T. Shiroto, Y. Ito, J. Y. Gao, K. Aizawa, Y. Kikuchi, K. Ito, J. Takahashi, H. Ishibashi-Ueda, et al.
Long-term treatment with nifedipine suppresses coronary hyperconstricting responses and inflammatory changes induced by paclitaxel-eluting stent in pigs in vivo: possible involvement of Rho-kinase pathway
Eur. Heart J., May 30, 2011; (2011) ehr145v1.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
H. Otake, Y. Honda, B. K. Courtney, T. Shimohama, J. Ako, K. Waseda, N. Macours, C. Rogers, J. J. Popma, A. Abizaid, et al.
Intravascular Ultrasound Results From the NEVO ResElution-I Trial: A Randomized, Blinded Comparison of Sirolimus-Eluting NEVO Stents With Paclitaxel-Eluting Taxus Liberte Stents in De Novo Native Coronary Artery Lesions
Circ Cardiovasc Interv, April 1, 2011; 4(2): 146 - 154.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Nakazawa, F. Otsuka, M. Nakano, M. Vorpahl, S. K. Yazdani, E. Ladich, F. D. Kolodgie, A. V. Finn, and R. Virmani
The Pathology of Neoatherosclerosis in Human Coronary Implants: Bare-Metal and Drug-Eluting Stents
J. Am. Coll. Cardiol., March 15, 2011; 57(11): 1314 - 1322.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
Y. Onuma and P. W. Serruys
Bioresorbable Scaffold: The Advent of a New Era in Percutaneous Coronary and Peripheral Revascularization?
Circulation, February 22, 2011; 123(7): 779 - 797.
[Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
T. Nakamura, B. C. Brott, I. Brants, D. Panchal, J. Li, J. P. Chen, S. B. King III, N. Chronos, and D. Hou
Vasomotor Function After Paclitaxel-Coated Balloon Post-Dilation in Porcine Coronary Stent Model
J. Am. Coll. Cardiol. Intv., February 1, 2011; 4(2): 247 - 255.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
Y. Onuma, P. W. Serruys, L. E. L. Perkins, T. Okamura, N. Gonzalo, H. M. Garcia-Garcia, E. Regar, M. Kamberi, J. C. Powers, R. Rapoza, et al.
Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: An Attempt to Decipher the Human Optical Coherence Tomography Images in the ABSORB Trial
Circulation, November 30, 2010; 122(22): 2288 - 2300.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, et al.
Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging Outcomes
Circulation, November 30, 2010; 122(22): 2301 - 2312.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
M. van den Heuvel, O. Sorop, W. W. Batenburg, C. L. Bakker, R. de Vries, S. J. Koopmans, H. M. M. van Beusekom, D. J. Duncker, A. H. J. Danser, and W. J. van der Giessen
Specific Coronary Drug-Eluting Stents Interfere With Distal Microvascular Function After Single Stent Implantation in Pigs
J. Am. Coll. Cardiol. Intv., July 1, 2010; 3(7): 723 - 730.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
M. Hara, M. Nishino, M. Taniike, N. Makino, H. Kato, Y. Egami, R. Shutta, H. Yamaguchi, J. Tanouchi, and Y. Yamada
Difference of Neointimal Formational Pattern and Incidence of Thrombus Formation Among 3 Kinds of Stents: An Angioscopic Study
J. Am. Coll. Cardiol. Intv., February 1, 2010; 3(2): 215 - 220.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
G. G. Camici, J. Steffel, I. Amanovic, A. Breitenstein, J. Baldinger, S. Keller, T. F. Luscher, and F. C. Tanner
Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents
Eur. Heart J., January 2, 2010; 31(2): 236 - 242.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
H. M.M. van Beusekom and P. W. Serruys
Drug-Eluting Stent Endothelium: Presence or Dysfunction
J. Am. Coll. Cardiol. Intv., January 1, 2010; 3(1): 76 - 77.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
T. Shiroto, S. Yasuda, R. Tsuburaya, Y. Ito, J. Takahashi, K. Ito, H. Ishibashi-Ueda, and H. Shimokawa
Role of Rho-Kinase in the Pathogenesis of Coronary Hyperconstricting Responses Induced by Drug-Eluting Stents in Pigs In Vivo
J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2321 - 2329.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Nickenig and J.-M. Sinning
Response to Drug-Eluting Stents: Do We Need Drugs to Recompense Drug Elution?
J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2330 - 2332.
[Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
L. K. Pendyala, X. Yin, J. Li, J. P. Chen, N. Chronos, and D. Hou
The First-Generation Drug-Eluting Stents and Coronary Endothelial Dysfunction
J. Am. Coll. Cardiol. Intv., December 1, 2009; 2(12): 1169 - 1177.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
J.-e. Obata, T. Nakamura, Y. Kitta, Y. Kodama, K. Sano, K.-I. Kawabata, Y. Saitoh, D. Fujioka, T. Kobayashi, T. Yano, et al.
Treatment of Acute Myocardial Infarction With Sirolimus-Eluting Stents Results in Chronic Endothelial Dysfunction in the Infarct-Related Coronary Artery
Circ Cardiovasc Interv, October 1, 2009; 2(5): 384 - 391.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Y. Onuma, P. Serruys, P. den Heijer, K. S. Joesoef, H. Duckers, E. Regar, N. Kukreja, S. Tanimoto, H. M. Garcia-Garcia, H. van Beusekom, et al.
MAHOROBA, first-in-man study: 6-month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenoses
Eur. Heart J., June 2, 2009; 30(12): 1477 - 1485.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
J. A. Ormiston and P. W.S. Serruys
Bioabsorbable Coronary Stents
Circ Cardiovasc Interv, June 1, 2009; 2(3): 255 - 260.
[Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
R. Chacko, M. Mulhearn, V. Novack, L. Novack, L. Mauri, S. A. Cohen, J. Moses, M. B. Leon, and D. E. Cutlip
Impact of Target Lesion and Nontarget Lesion Cardiac Events on 5-Year Clinical Outcomes After Sirolimus-Eluting or Bare-Metal Stenting
J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 498 - 503.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
R. A. Vogel
Drug-Eluting Stents: Safe But Not Sufficient
J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 513 - 514.
[Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
B. Chevalier, S. Silber, S.-J. Park, E. Garcia, G. Schuler, H. Suryapranata, J. Koolen, K. E. Hauptmann, W. Wijns, M.-C. Morice, et al.
Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberte Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries: The NOBORI 1 Trial--Phase 2
Circ Cardiovasc Interv, June 1, 2009; 2(3): 188 - 195.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
S. Brugaletta, V. Martin Yuste, and M. Sabate
Letter by Brugaletta et al Regarding Article, "Interference of Drug-Eluting Stents and Endothelium-Dependent Coronary Vasomotion: Evidence for Device-Specific Responses"
Circ Cardiovasc Interv, April 1, 2009; 2(2): e1 - e1.
[Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
W. J. van der Giessen, O. Sorop, P. W. Serruys, I. Peters-Krabbendam, and H. M.M. van Beusekom
Lowering the Dose of Sirolimus, Released From a Nonpolymeric Hydroxyapatite Coated Coronary Stent, Reduces Signs of Delayed Healing
J. Am. Coll. Cardiol. Intv., April 1, 2009; 2(4): 284 - 290.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
M. Hamilos, J. Sarma, M. Ostojic, T. Cuisset, G. Sarno, N. Melikian, A. Ntalianis, O. Muller, E. Barbato, B. Beleslin, et al.
Interference of Drug-Eluting Stents With Endothelium-Dependent Coronary Vasomotion: Evidence for Device-Specific Responses
Circ Cardiovasc Interv, December 1, 2008; 1(3): 193 - 200.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
N. Kukreja, Y. Onuma, H. Garcia-Garcia, J. Daemen, R. van Domburg, and P. W. Serruys
Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Long-Term Outcome After Bare Metal and Drug-Eluting Stent Implantation
Circ Cardiovasc Interv, October 1, 2008; 1(2): 103 - 110.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. Wenaweser, J. Daemen, M. Zwahlen, R. van Domburg, P. Juni, S. Vaina, G. Hellige, K. Tsuchida, C. Morger, E. Boersma, et al.
Incidence and Correlates of Drug-Eluting Stent Thrombosis in Routine Clinical Practice: 4-Year Results From a Large 2-Institutional Cohort Study
J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1134 - 1140.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
C. J. Pepine
Provoked Coronary Spasm and Acute Coronary Syndromes
J. Am. Coll. Cardiol., August 12, 2008; 52(7): 528 - 530.
[Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
J. D. Abbott
Revealing the Silver and Red Lining in Drug-Eluting Stents With Angioscopy
Circ Cardiovasc Interv, August 1, 2008; 1(1): 7 - 9.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Joner, G. Nakazawa, A. V. Finn, S. C. Quee, L. Coleman, E. Acampado, P. S. Wilson, K. Skorija, Q. Cheng, X. Xu, et al.
Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 333 - 342.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. I. Hamilos, M. Ostojic, B. Beleslin, D. Sagic, L. Mangovski, S. Stojkovic, M. Nedeljkovic, D. Orlic, B. Milosavljevic, D. Topic, et al.
Differential Effects of Drug-Eluting Stents on Local Endothelium-Dependent Coronary Vasomotion
J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2123 - 2129.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Jabs, S. Gobel, P. Wenzel, A. L. Kleschyov, M. Hortmann, M. Oelze, A. Daiber, and T. Munzel
Sirolimus-Induced Vascular Dysfunction: Increased Mitochondrial and Nicotinamide Adenosine Dinucleotide Phosphate Oxidase-Dependent Superoxide Production and Decreased Vascular Nitric Oxide Formation
J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2130 - 2138.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. B. Muhlestein
Endothelial Dysfunction Associated With Drug-Eluting Stents: What, Where, When, and How?
J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2139 - 2140.
[Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
J. Li, R. Jabara, L. Pendyala, Y. Otsuka, T. Shinke, D. Hou, K. Robinson, and N. Chronos
Abnormal Vasomotor Function of Porcine Coronary Arteries Distal to Sirolimus-Eluting Stents
J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 279 - 285.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
C. Cheng, D. Tempel, A. Oostlander, F. Helderman, F. Gijsen, J. Wentzel, R. van Haperen, D. B. Haitsma, P. W. Serruys, A. F. W. van der Steen, et al.
Rapamycin modulates the eNOS vs. shear stress relationship
Cardiovasc Res, April 1, 2008; 78(1): 123 - 129.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. L. Pinto Slottow and R. Waksman
Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel Meeting on the Endeavor Zotarolimus-Eluting Coronary Stent
Circulation, March 25, 2008; 117(12): 1603 - 1608.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Nakazawa, Q. Cheng, X. Xu, A. V. Finn, F. D. Kolodgie, and R. Virmani
Drug-Eluting Stent Implantation May Not Affect Vasomotor Function in Early Phase
J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1124 - 1125.
[Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
J. W. Kim, S. Y. Suh, C. U. Choi, J. O. Na, E. J. Kim, S.-W. Rha, C. G. Park, H. S. Seo, and D. J. Oh
Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.
J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 65 - 71.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
M. J. Kern
Persistent endothelial dysfunction after drug-eluting stents another continuing cost of reducing restenosis.
J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 72 - 73.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
P. J. Vlaar, B. J. G. L. de Smet, and F. Zijlstra
DES or BMS in acute myocardial infarction?
Eur. Heart J., November 2, 2007; 28(22): 2693 - 2694.
[Full Text] [PDF]

Home page
 CirculationHome page
S. Windecker and B. Meier
Late Coronary Stent Thrombosis
Circulation, October 23, 2007; 116(17): 1952 - 1965.
[Full Text] [PDF]

Home page
 CirculationHome page
E. Camenzind, P. G. Steg, and W. Wijns
Response to Letter Regarding Article, "Stent Thrombosis Late After Implantation of First-Generation Drug-Eluting Stents: A Cause for Concern"
Circulation, October 16, 2007; 116(16): e390 - e390.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J.-e. Obata, Y. Kitta, H. Takano, Y. Kodama, T. Nakamura, A. Mende, K.-i. Kawabata, Y. Saitoh, D. Fujioka, T. Kobayashi, et al.
Sirolimus-Eluting Stent Implantation Aggravates Endothelial Vasomotor Dysfunction in the Infarct-Related Coronary Artery in Patients With Acute Myocardial Infarction
J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1305 - 1309.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. Daemen and P. W. Serruys
Drug-Eluting Stent Update 2007: Part II: Unsettled Issues
Circulation, August 21, 2007; 116(8): 961 - 968.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. Meier and C. Seiler
Reply
J. Am. Coll. Cardiol., August 7, 2007; 50(6): 561 - 561.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. Jaffe and B. H. Strauss
Late and Very Late Thrombosis of Drug-Eluting Stents: Evolving Concepts and Perspectives
J. Am. Coll. Cardiol., July 10, 2007; 50(2): 119 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. V. Finn, G. Nakazawa, M. Joner, F. D. Kolodgie, E. K. Mont, H. K. Gold, and R. Virmani
Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing
Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1500 - 1510.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Menichelli, A. Parma, E. Pucci, R. Fiorilli, F. De Felice, M. Nazzaro, A. Giulivi, D. Alborino, A. Azzellino, and R. Violini
Randomized Trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI)
J. Am. Coll. Cardiol., May 15, 2007; 49(19): 1924 - 1930.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
G. M. Howard-Alpe, J. de Bono, L. Hudsmith, W. P. Orr, P. Foex, and J. W. Sear
Coronary artery stents and non-cardiac surgery
Br. J. Anaesth., May 1, 2007; 98(5): 560 - 574.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Ghatta, R. R. Tunstall, S. Kareem, M. Rahman, and S. T. O'Rourke
Sirolimus Causes Relaxation of Human Vascular Smooth Muscle: A Novel Action of Sirolimus Mediated via ATP-Sensitive Potassium Channels
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1204 - 1208.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. Meier, R. Zbinden, M. Togni, P. Wenaweser, S. Windecker, B. Meier, and C. Seiler
Coronary Collateral Function Long After Drug-Eluting Stent Implantation
J. Am. Coll. Cardiol., January 2, 2007; 49(1): 15 - 20.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Zimarino, A. Ausiello, G. Contegiacomo, I. Riccardi, G. Renda, C. Di Iorio, and R. De Caterina
Rapid Decline of Collateral Circulation Increases Susceptibility to Myocardial Ischemia: The Trade-Off of Successful Percutaneous Recanalization of Chronic Total Occlusions
J. Am. Coll. Cardiol., July 4, 2006; 48(1): 59 - 65.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Tsimikas
Drug-Eluting Stents and Late Adverse Clinical Outcomes: Lessons Learned, Lessons Awaited
J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2112 - 2115.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Togni and O. M. Hess
Reply
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1912 - 1913.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
N. Kipshidze and M. B. Leon
Endothelial Dysfunction After Drug-Eluting Stent Was Never Predicted in Preclinical Studies
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1911 - 1911.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Wheatcroft, J. Byrne, M. Thomas, and P. MacCarthy
Life-Threatening Coronary Artery Spasm Following Sirolimus-Eluting Stent Deployment
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1911 - 1912.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. J. Gomes and E. Buffolo
Coronary stenting and inflammation: implications for further surgical and medical treatment.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1918 - 1925.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. Wessely, A. Schomig, and A. Kastrati
Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting Stents: Similar But Different
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 708 - 714.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S. H. Hofma, W. J. van der Giessen, B. M. van Dalen, P. A. Lemos, E. P. McFadden, G. Sianos, J. M.R. Ligthart, D. van Essen, P. J. de Feyter, and P. W. Serruys
Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation
Eur. Heart J., January 2, 2006; 27(2): 166 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Lerman and E. Eeckhout
Coronary endothelial dysfunction following sirolimus-eluting stent placement: should we worry about it?
Eur. Heart J., January 2, 2006; 27(2): 125 - 126.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. Serry and W. F. Penny
Endothelial Dysfunction After Sirolimus-Eluting Stent Placement
J. Am. Coll. Cardiol., July 19, 2005; 46(2): 237 - 238.
[Full Text] [PDF]


 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement